BioAtla BCAB
OTC BCAB
$1.45 +0.12 (+9.02%)
As of: Oct 21, 2026 · 12:24 PM EDT

BioAtla (BCAB) EBT Margin (2020 - 2026)

Updated

BioAtla's EBT Margin was 3.74% in Q2 2026.

Analysis

BioAtla (BCAB) EBT Margin (2020 - 2026) Analysis & Trends

On a trailing twelve-month basis, BioAtla's EBT Margin was -374.89% through Jun 30, 2026, up 187.80 percentage points year-over-year; for FY2025, it was -2923.10%, down 2281.52 percentage points from FY2024.

  • EBT Margin shows a five-year change of +4393.45 percentage points (FY2020 to FY2025).
  • In earlier years, EBT Margin was -641.58% in FY2024 and -38437.20% in FY2021 (-31120.65 pp).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 40.25%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 26.66%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 25.18%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn -4.11%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 29.63%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 18.19%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 27.53%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -131.41%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn -4.34%
10 BioAtla 2.41 Mn -16.54 Mn - 3.74%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.74%
Dec 31, 2025 -459.10%
Sep 30, 2024 -96.16%
Jun 30, 2024 -2,341.33%
Jun 30, 2021 -12,152.40%
Sep 30, 2020 -5,380.00%
Jun 30, 2020 -2,775.26%
Mar 31, 2020 -1,855.06%
API Access

BioAtla EBT Margin API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebt-margin&ticker=BCAB&period=max&api_key=YOUR_API_KEY